Ron Renaud

Ron Renaud is the President and CEO of Kailera Therapeutics, a role they commenced in 2024. With extensive experience in the biotechnology and pharmaceuticals sectors, Ron has held positions such as Chief Financial Officer and Chief Business Officer at Idenix Pharmaceuticals and Chief Executive Officer at Translate Bio. They have also contributed to various boards, including serving as a board member at Cardurion Pharmaceuticals and as Chairperson at Atara Biotherapeutics. Educated with a BA in Psychology from Saint Anselm College and an MBA in Finance from USC Marshall School of Business, Ron has a strong background in financial analysis and equity research.